BioSafety Technologies, a subsidiary of Terahertz Group Ltd., was established in late spring of 2020, during the onset of the COVID-19 pandemic, focusing on biosafety solutions by leveraging its ultra-sensitive Terahertz (“THz” = 300-3,000GHz) molecular radar detection technology of viruses and bacterial infections. Our BioSafety Station enables noninvasive COVID-19 test, based on breath analysis, in less than 60 seconds per test with an instant result.